# PLA2G4D

## Overview
PLA2G4D is a gene that encodes the enzyme phospholipase A2 group IVD, a member of the cytosolic phospholipase A2 (cPLA2) family. This enzyme is primarily involved in the hydrolysis of membrane phospholipids, leading to the release of arachidonic acid, a precursor for the synthesis of prostaglandins and other eicosanoids. These signaling molecules are crucial in mediating inflammatory responses and various physiological processes, including labor and skin barrier function (Liu2017Associations; Murakami2020Updating). The PLA2G4D gene is notably expressed in keratinocytes, where it plays a significant role in skin health and disease, particularly in conditions such as psoriasis and pityriasis rubra pilaris (PRP) (Shao2021Phospholipase). The enzyme's activity, which includes a preference for PLA1 over PLA2, influences lipid metabolism and immune responses, making it a potential target for therapeutic interventions in inflammatory skin disorders (Taketomi2022Regulatory).

## Function
PLA2G4D encodes a member of the cytosolic phospholipase A2 (cPLA2) family, specifically the δ isoform, which is involved in the hydrolysis of membrane phospholipids to release arachidonic acid. This process is crucial for the synthesis of prostaglandins (PGs), which are signaling molecules that play significant roles in inflammatory pathways and immune responses (Liu2017Associations). In healthy human cells, PLA2G4D is implicated in the regulation of prostaglandin synthesis, which is essential for normal labor processes by facilitating the transition of the myometrium from a quiescent to a contractile state (Liu2017Associations).

PLA2G4D is also expressed in keratinocytes, where it is involved in skin barrier function and keratinocyte differentiation. It has been identified as a keratinocyte-specific isoform that is highly induced during conditions like psoriasis, suggesting its role in skin health and disease (Murakami2020Updating). The enzyme exhibits PLA1 activity in preference to PLA2 activity, which may influence the types of lipid metabolites produced and their subsequent biological effects (Taketomi2022Regulatory). These activities highlight the enzyme's involvement in both normal physiological processes and pathological conditions.

## Clinical Significance
Alterations in the expression of the PLA2G4D gene have been implicated in the pathogenesis of psoriasis and pityriasis rubra pilaris (PRP). These conditions are characterized by inflammatory and hyperproliferative skin responses. PLA2G4D is overexpressed in the epidermis of individuals with psoriasis and PRP, suggesting a shared pathogenic mechanism between these diseases (Shao2021Phospholipase). The enzyme encoded by PLA2G4D, a cytosolic phospholipase A2, is involved in lipid metabolism, which affects immune responses and skin barrier function. Its upregulation in response to proinflammatory cytokines like TNF and IL-17A contributes to the inflammatory processes observed in these skin disorders (Shao2021Phospholipase).

PLA2G4D also plays a role in promoting the expression of CD1a in psoriatic mast cells, which can be recognized by lipid-specific CD1a-reactive T cells. This interaction leads to the production of cytokines such as IL-22 and IL-17A, further driving inflammation and epidermal proliferation in psoriasis (Shao2021Phospholipase). These findings suggest that targeting PLA2G4D could be a potential therapeutic strategy for managing psoriasis and PRP (Shao2021Phospholipase).


## References


[1. (Liu2017Associations) Guang-Jian Liu, Jian-Rong He, Ya-Shu Kuang, Xue-Jiao Fan, Wei-Dong Li, Jin-Hua Lu, Xiao-Yan Xia, Xiao-Dan Liu, Nian-Nian Chen, Wei-Bi Mai, Hui-Min Xia, and Xiu Qiu. Associations of maternal pla2g4c and pla2g4d polymorphisms with the risk of spontaneous preterm birth in a chinese population. Molecular Medicine Reports, 15(6):3607–3614, April 2017. URL: http://dx.doi.org/10.3892/mmr.2017.6475, doi:10.3892/mmr.2017.6475. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2017.6475)

[2. (Taketomi2022Regulatory) Yoshitaka Taketomi and Makoto Murakami. Regulatory roles of phospholipase a2 enzymes and bioactive lipids in mast cell biology. Frontiers in Immunology, June 2022. URL: http://dx.doi.org/10.3389/fimmu.2022.923265, doi:10.3389/fimmu.2022.923265. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2022.923265)

[3. (Shao2021Phospholipase) Shuai Shao, Jiaoling Chen, William R. Swindell, Lam C. Tsoi, Xianying Xing, Feiyang Ma, Ranjitha Uppala, Mrinal K. Sarkar, Olesya Plazyo, Allison C. Billi, Rachael Wasikowski, Kathleen M. Smith, Prisca Honore, Victoria E. Scott, Emanual Maverakis, J. Michelle Kahlenberg, Gang Wang, Nicole L. Ward, Paul W. Harms, and Johann E. Gudjonsson. Phospholipase a2 enzymes represent a shared pathogenic pathway in psoriasis and pityriasis rubra pilaris. JCI Insight, October 2021. URL: http://dx.doi.org/10.1172/jci.insight.151911, doi:10.1172/jci.insight.151911. This article has 37 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1172/jci.insight.151911)

[4. (Murakami2020Updating) Makoto Murakami, Hiroyasu Sato, and Yoshitaka Taketomi. Updating phospholipase a2 biology. Biomolecules, 10(10):1457, October 2020. URL: http://dx.doi.org/10.3390/biom10101457, doi:10.3390/biom10101457. This article has 127 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom10101457)